FDA Approves Dapagliflozin (Farxiga) for Continual Kidney Illness
The US Meals and Drug Administration (FDA) has well-liked dapagliflozin (Farxiga, AstraZeneca) to in the reduction of the possibility for kidney honest decline, kidney failure, cardiovascular loss of life, and hospitalization for heart failure in grownup patients with power kidney…